Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.13 | 0.4 |
mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |